FDA cleared acalabrutinib plus venetoclax as the only all-oral, fixed-dose combination option for first-line, treatment-naïve CLL/SLL. Phase 3 AMPLIFY showed superior PFS versus chemoimmunotherapy, ...

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. It affects people of all ages but is most common in those over 65. Around 150 people are diagnosed with the disease each year in ...

A South Coast teenager is in the fight of his life, and his mother is appealing to the public to help by registering to ...

Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the ...

In a new study published in Nature Communications, a research team at the University of Oslo have examined how cancer cells ...

Leukemia causes uncontrollable growth and reproduction of cells called leukocytes. In acute leukemia, leukocytes are less mature, develop fast, and become dysfunctional cells called blasts as they ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the combination regimen of Venclexta® (venetoclax) ...

Skidaway Island resident Bruce Koehler is among early participants seeing clinical blood‑count improvements in a nationwide ...

What do healthy bone marrow cells in children look like? For the first time, researchers have mapped this out. Scientists at the Princess Máxima Center examined nearly 91,000 individual bone marrow ...

Getting a diagnosis of leukemia can feel overwhelming. But multiple treatment options and support organizations can help you on your journey after diagnosis. Leukemia is a type of cancer that affects ...

Tony Garcia, who survived leukemia as a child back in the 1970s and '80s when a diagnosis was practically a death sentence, has written a book about the experience. "My Childhood Cut Short — ...

The Make-A-Wish foundation is sending a Maine teen to the Super Bowl.Fifteen-year-old Avery MacNair has been a New England ...